Human beta-defensin chimeric peptides
This invention exploits the remarkable differences in the antimicrobial properties shown by human beta-defensins 2 and 3 (HBD2 and HBD3) against Gram-positive and Gram-negative bacteria through the generation of chimeric molecules of HBD2 and HBD3 with improved activity against E.coli and S.aureus strains compared to wild-type. The chimeras are very interesting novel molecules, based on the natural human proteins, which offer a combined and improved defensin activity.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
Media Contact
All latest news from the category: Technology Offerings
Newest articles
The Sound of the Perfect Coating
Fraunhofer IWS Transfers Laser-based Sound Analysis of Surfaces into Industrial Practice with “LAwave”. Sound waves can reveal surface properties. Parameters such as surface or coating quality of components can be…
Customized silicon chips
…from Saxony for material characterization of printed electronics. How efficient are new materials? Does changing the properties lead to better conductivity? The Fraunhofer Institute for Photonic Microsystems IPMS develops and…
Acetylation: a Time-Keeper of glucocorticoid Sensitivity
Understanding the regulatory mechanism paves the way to enhance the effectiveness of anti-inflammatory therapies and to develop strategies to counteract the negative effects of stress- and age-related cortisol excess. The…